Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Compare which has lower fees between index funds and target date retirement options to understand true costs and impact on returns. Make smarter retirement choices with clear, practical guidance.
28,375 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...
Broadcom just cratered 16% in a month, triggering a much-needed debate among investors: Is this a buying dip or the s...
Brown Harris Stevens adds Debbie Baum, a seasoned Manhattan real estate broker, from Corcoran. The move expands the f...
Insiders are loading up Arbor Realty Trust while bears keep a large short position. The clash over who’s right Arbor ...
Pinterest has shown strong quarterly results, yet the stock moves on mixed signals. This guide breaks down the what's...
As AI-driven demand accelerates, the real trade sits with the equipment suppliers that power chip production. ASML, A...
Nvidia still dominates AI hardware, but the stock's sparkle has cooled. This article breaks down the three big reason...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
When headlines talk about a stock suddenly bleeding, traders worry about customer losses and slowing growth. This art...
Investors are weighing AI-driven promises against advertising risks as Alphabet and META steer big bets into the futu...